Maryland · 2026 Regular Session · Bill

SB 987: Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

In committee Last action March 5, 2026: Hearing 3/11 at 1:00 p.m.

Plain-language summary

SB 987 is a bill introduced in the Maryland Senate on February 15, 2026. According to its official title, it concerns: Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising. Primary sponsor: Karen Young (Democratic). Most recent recorded action (March 5, 2026): Hearing 3/11 at 1:00 p.m.

Sponsors

Primary sponsor: Karen Young (Democratic).